Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 09:11, 16 July 2024 DDeel talk contribs deleted page Dale, PS (content was: "{{Author}}", and the only contributor was "JDoerfler" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Vitale, MG; Barbato, C; Crispo, A; Habetswallner, F; De Martino, BM; Riccardi, F; Maione, A; Eisenwagen, S; Vitale, G; Cartenì, G (content was: "{{Author}} In this study, 120 patients were randomly divided into 2 groups. One group received a preparation containing zeolite, and the other group received a placebo. The occurrence and severity of peripheral neuropathy due to oxaliplatin chemotherapy were measured. After 6 months, no differences in occurrence or severity were found between the groups. Further analyses se...", and the only contributor was "Lbordihn" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Vitale et al.: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (content was: "{{Author}}", and the only contributor was "Lbordihn" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Santos, I. K. F. M (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Rocha, J. J. R (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Ribeiro, S. M. F (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Peria, F. M (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Nguyen, M.; Ahmann, F.; Nagle, R.; Hsu, C.-H.; Tangrea, J.; Parnes, H.; Sokoloff, M.; Gretzer, M.; Chow, H.-H. S. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Moghaddam, A. A (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Martinez, E. Z (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:09, 16 July 2024 DDeel talk contribs deleted page Lian, S. B.; Xu, Y.; Goh, S. L.; Aw, F. C. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:08, 16 July 2024 DDeel talk contribs deleted page Laali, E.; Manifar, S.; Kazemian, A.; Jahangard-Rafsanjani, Z.; Gholami, K. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:08, 16 July 2024 DDeel talk contribs deleted page Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:08, 16 July 2024 DDeel talk contribs deleted page Henning, S. M.; Wang, P.; Said, J. W.; Huang, M.; Grogan, T.; Elashoff, D.; Carpenter, C. L.; Heber, D.; Aronson, W. J. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:08, 16 July 2024 DDeel talk contribs deleted page Emami, H., Nikoobin, F., Roayaei, M., Ziya, H. R. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:07, 16 July 2024 DDeel talk contribs deleted page Cunha, S. F. C (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:07, 16 July 2024 DDeel talk contribs deleted page Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Chang, J.; Rimawi, M.; Vornik, L.; Cornelison, T. L.; Wang, A.; Hibshoosh, H.; Ahmed, A.; Terry, M. B.; Santella, R. M.; Lippman, S. M.; Hershman, D. L. (content was: "{{Author}}", and the only contributor was "EProba" (talk))
• 09:07, 16 July 2024 DDeel talk contribs deleted page Braga, C. B. M (content was: "{{Author}}", and the only contributor was "CHoppe" (talk))
• 09:07, 16 July 2024 DDeel talk contribs deleted page Avishek Anand (content was: "{{Author}}", and the only contributor was "Cotto" (talk))
• 07:22, 16 July 2024 JDoerfler talk contribs created page Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Publication |Title=Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients |Topic=Curcumin |Author=Ryan, JL; Heckler, CE; Ling, M; Katz, A; Williams, JP; Pentland, AP; Morrow, GR |Year=2013 |Journal=Journal of Radiation Research |DOI=https://doi.org/10.1667/RR3255.1 |Authors Abstract=Radiation dermatitis occurs in approximately 95% of patients receiving radiotherapy (RT) for breast cancer. We con...")
• 14:18, 15 July 2024 JDoerfler talk contribs created page Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Reference |Reference=Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study }} {{Study Note}} =Brief summary= This study investigated the efficacy of a curcumin mouth rinse compared to a povidone-iodine mouth rinse in patients with head and neck cancer during radiotherapy. Throughout radiotherapy, mucositis (an inflammation of the mucosa, a common a...")
• 13:47, 15 July 2024 JDoerfler talk contribs created page Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Publication |Title=The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study |Topic=Curcumin |Author=Rao, S; Dinkar, C; Vaishnav, LK; Rao, P; Rai, MP; Fayad, R; Baliga, MS |Year=2014 |Journal=Integrative Cancer Therapies |DOI=https://doi.org/10.1177/1534735413503549 |Authors Abstract=Purpose. Radiation-induced oral mucositis is an acute morbidity seen in patients u...")
• 13:15, 15 July 2024 JDoerfler talk contribs created page Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Reference |Reference=Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were examined during radiotherapy. The patients were instructed to apply a gel to the entire oral cavity 3 times a day, with half receiving a curcumin gel and the other half a placebo gel. There were more cases of severe mucositis (an inf...")
• 13:09, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Publication |Title=The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer |Topic=Curcumin |Author=Mansourian, A; Amanlou, M; Shirazian, Sh; Moosavian Jahromi, Z; Amirian, A |Year=2015 |Journal=International Journal of Radiation Research |DOI=https://doi.org/10.7508/ijrr.2015.03.011 |Authors Abstract=Background: Different treatment and protective approaches for radiation-induced oral mucositis have been pract...")
• 12:30, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo cap...")
• 12:29, 15 July 2024 JDoerfler talk contribs created page Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Publication |Title=Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Hejazi, E; Ehtejab, G; Hara, N |Year=2016 |Journal=Nutrition and Cancer |DOI=https://doi.org/10.1080/01635581.2016.1115527 |Authors Abstract=Curcumin is an antioxidant agent with both radiosensitizing and radioprot...")
• 12:23, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Reference |Reference=Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo capsules instead. In the first study of XX, the quality...")
• 11:56, 15 July 2024 JDoerfler talk contribs created page Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Publication |Title=A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Ehtejab, G |Year=2013 |Journal=Journal of Cancer Science and Therapy |DOI=http://dx.doi.org/10.4172/1948-5956.1000223 |Authors Abstract=Background: Patients with prostate cancer who accede to radiation therapy usually experience several side effects and these toxicit...")
• 09:41, 15 July 2024 JDoerfler talk contribs created page Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Reference |Reference=Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study }} {{Study Note}} =Brief summary= Cisplatin is an effective chemotherapeutic agent. However, cisplatin is toxic to the outer hair cells of the ears and can cause hearing loss in patients receiving this therapy. In this study, the researchers tested the effect of Ginkgo biloba extract at a dose of 120 mg twice daily to prevent damage to...")
• 09:40, 15 July 2024 JDoerfler talk contribs created page Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Publication |Title=The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study |Topic=Ginkgo |Author=Dias, MA; Sampaio, ALL; Venosa, AR; Meneses, EA; Oliveira, CACP |Year=2015 |Journal=International Tinnitus Journal |DOI=https://doi.org/10.5935/0946-5448.20150003 |Authors Abstract=Objective: The purpose of this study was to evaluate, by using distortion product otoacoustic emission test, the action of Ginkgo biloba extract 761,...")
• 08:53, 15 July 2024 JDoerfler talk contribs created page Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Reference |Reference=Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 }} {{Study Note}} =Brief summary= Differentiated thyroid cancer (DTC) is a type of thyroid cancer that has developed in the cells of the thyroid gland that are responsible for the production of thyroid hormones. DTC is usually treated by removing the thyroid gland followed by radio...")
• 08:49, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Publication |Title=The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 |Topic=Ginkgo |Author=Dardano, A; Ballardin, M; Caraccio, N; Boni, G; Traino, C; Mariani, G; Ferdeghini, M; Barale, R; Monzani, F |Year=2012 |Journal=Thyroid |DOI=https://doi.org/10.1089/thy.2010.0398 |Authors Abstract=Background: Radioiodine (131I) therapy is usually performed in patients with d...")
• 08:27, 15 July 2024 JDoerfler talk contribs deleted page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors (content was: "{{Publication |Title=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial |Topic=Boswellia serrata |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors often suffer...")
• 12:55, 12 July 2024 Lbordihn talk contribs created page Publication: Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial (Created page with "{{Publication |Title=Publication: Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial |Topic=Frankincense (boswelia) |Author=Togni S; Maramaldi G; Bonetta A; Giacomelli L; Di Pierro F |Year=2015 |Journal=European Review for Medical and Pharmacological Sciences |Authors Abstract=OBJECTIVE: Acute radiation ery- thema and other skin reactions are c...")
• 09:15, 12 July 2024 JDoerfler talk contribs created page Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 (Created page with "{{Reference |Reference=Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer }} {{Study Note}} =Brief summary= Patients receiving chemotherapy often describe a decline in cognitive function (known as "chemo brain") that remains for months or years after chemotherapy has ended. As breast cancer survival rates improve, more attention is being paid to this side effect on...")
• 08:56, 12 July 2024 JDoerfler talk contribs created page Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer (Created page with "{{Publication |Title=The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer |Topic=Ginkgo |Author=Barton, DL; Burger, K; Novotny, PJ; Fitch, TR; Kohli, S; Soori, G; Wilwerding, MB; Sloan, JA; Kottschade, L.A; Rowland, KM; Dakhil, SR; Nikcevich, DA; Loprinzi, CL |Year=2013 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-012-1647-9 |Authors Abstract=Purpose Patient...")
• 07:39, 12 July 2024 JDoerfler talk contribs created page Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
• 07:37, 12 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Publication |Title=Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial |Topic=Vitamin E |Author=Villani, V; Zucchella, C; Cristalli, G; Galie, E; Bianco, F; Giannarelli, D; Carpano, S; Spriano, G; Pace, A |Year=2016 |Journal=Head and Neck |DOI=https://doi.org/10.1002/hed.24396 |Authors Abstract=Background. Few studies have investigated the effect of vitamin E in reducing the cisplatin (CDDP)-induced...")
• 15:25, 11 July 2024 Lbordihn talk contribs created page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial (Created page with "{{Publication |Title=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial |Topic=Frankincense (boswelia) |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors o...")
• 13:09, 11 July 2024 Lbordihn talk contribs created page Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial (Created page with "{{Reference |Reference=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial }} {{Study Note}} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysi...")
• 13:01, 11 July 2024 Lbordihn talk contribs created page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors (Created page with "{{Publication |Title=Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors |Topic=Boswellia |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors often suffer from cerebral edema and are usually treated with dexamethason...")
• 08:57, 11 July 2024 MKraft talk contribs created page Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This is the second study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, rando...")
• 08:54, 11 July 2024 MKraft talk contribs created page Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This study is the first study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind,...")
• 08:48, 11 July 2024 MKraft talk contribs created page Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Publication |Title=Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies |Topic=Cannabinoids |Author=Fallon, M T; Lux, E A; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S; Lichtman, A H; Kornyeyeva, E |Year=2017 |Journal=British Journal of Pain |DOI=https://doi.org/10.1177/2049463717710042 |Authors Abstract=Backgrou...")
• 08:12, 11 July 2024 JDoerfler talk contribs created page Upadhyaya et al. (2017): Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Reference |Reference=Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= In this study, the protective effect of vitamin E on radiotherapy-induced functional impairment of the salivary glands (auricular and submandibular salivary glands) in patients with thyroid cancer was investigated. The patients were divided into...")
• 08:01, 11 July 2024 JDoerfler talk contribs created page Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Publication |Title=Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial |Topic=Vitamin E |Author=Upadhyaya, A; Zhou, P; Meng, Z; Wang, P; Zhang, G; Jia, Q; Tan, J; Li, X; Hu, T; Liu, N; Wang, S; Liu, X; Wang, H; Zhang, C; Zhao, F; Yan, Z; Wang, X; Zhang, X; Zhang, W |Year=2017 |Journal=Nuclear Medicine Communications |DOI=https://doi.org/10.1097/MNM.0000000000000727 |Authors Abst...")
• 11:30, 10 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
• 11:30, 10 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
• 11:22, 10 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants...", and the only contributor was "Cotto" (talk))